B-SOFT Co Ltd
B-SOFT's capital structure is characterized by a low debt-to-equity ratio of 0.02, indicating a conservative leverage profile. However, the company's liquidity is rated as medium, with a current ratio of 2.38, suggesting it can cover short-term obligations but with limited excess capacity. Free cash flow is negative at -390.36 million CNY, and operating cash flow is also negative at -21.20 million CNY, signaling cash flow constraints. Profitability metrics are weak, with a return on equity (ROE) of -10.02% and a return on assets (ROA) of -7.61%. These figures are below the typical thresholds for healthy performance in the healthcare equipment industry. The company reported a net loss of 401.65 million CNY and an operating loss of 414.32 million CNY, indicating significant operational challenges. Geographic and segment exposure is not explicitly detailed in the available data, but the company operates primarily in the healthcare equipment segment. Revenue concentration data is not provided, but the absence of disclosed international operations suggests a domestic focus. The company's growth trajectory is uncertain, with no specific revenue growth projections provided. Historical revenue for the latest period was 1.05 billion CNY, but the lack of prior-year data prevents a year-over-year comparison. Analysts have assigned a mean price target of 6.37 CNY, with a median of 6.38 CNY, and a strong buy recommendation from two analysts. Risk factors include liquidity constraints, as the company has negative net cash after subtracting total debt. The dilution risk is currently low, with no near-term pressure from share issuance or convertible instruments. However, the company's operating losses and negative cash flows could necessitate future capital raises, which may dilute existing shareholders. Recent events include the publication of the latest financial results, which show a significant operating and net loss. No recent filings or transcripts are available to provide additional context on the company's strategic direction or operational performance.
Business. B-SOFT Co Ltd is a Chinese company specializing in healthcare equipment, providing products and services in the advanced medical equipment and technology sector.
Classification. B-SOFT is classified under the Healthcare sector, specifically in the Healthcare Services & Equipment business sector, with a confidence level of 0.92.
- B-SOFT has a low debt-to-equity ratio but faces liquidity constraints due to negative free and operating cash flows.
- The company is unprofitable, with a return on equity of -10.02% and a return on assets of -7.61%.
- Analysts have a positive outlook, with a mean price target of 6.37 CNY and a strong buy recommendation.
- The company's growth trajectory is unclear, with no specific revenue growth projections provided.
- Liquidity risk is a key concern, as the company has negative net cash after subtracting total debt.
- --
- ## RATIONALES
- ```json
- Net cash is negative after subtracting total debt.